Emergent BioSolutions
EBS
#6710
Rank
โ‚น59.86 B
Marketcap
โ‚น1,122
Share price
8.06%
Change (1 day)
49.17%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: โ‚น59.86 Billion

As of December 2025 Emergent BioSolutions has a market cap of โ‚น59.86 Billion. This makes Emergent BioSolutions the world's 6710th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น59.86 B55.72%
2024โ‚น38.44 B270.83%
2023โ‚น10.36 B-78.74%
2022โ‚น48.75 B-71.99%
2021โ‚น174.06 B-49.88%
2020โ‚น347.29 B74.61%
2019โ‚น198.90 B-6.28%
2018โ‚น212.22 B43.35%
2017โ‚น148.04 B63.81%
2016โ‚น90.37 B-13.74%
2015โ‚น104.77 B61%
2014โ‚น65.07 B25.11%
2013โ‚น52.01 B65.13%
2012โ‚น31.50 B-1.64%
2011โ‚น32.02 B-12.98%
2010โ‚น36.80 B89.31%
2009โ‚น19.44 B-48.23%
2008โ‚น37.55 B535.61%
2007โ‚น5.90 B-56.69%
2006โ‚น13.64 B

End of Day market cap according to different sources

On Dec 15th, 2025 the market cap of Emergent BioSolutions was reported to be:

โ‚น59.04 Billion
by Nasdaq info icon info icon
โ‚น59.86 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
โ‚น22.788 T 37,969.40%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น41.18 B-31.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น9.050 T 15,019.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚น163.81 B 173.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.674 T 22,744.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น3.145 T 5,154.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
โ‚น1.42 B-97.62%๐Ÿ‡บ๐Ÿ‡ธ USA